Title: Post-Stroke Gut Microbiota Dysbiosis: Mechanisms, Clinical Evidence, and Therapeutic Frontiers

Authors: Dr Keemaya Gurudutt Joglekar, M.B.B.S., Dr Amit Ajit Desai, M.S., M.R.C.S, FIAGES

 DOI: https://dx.doi.org/10.18535/jmscr/v13i10.02

Abstract

 

Stroke remains a leading cause of death and disability worldwide, yet therapeutic strategies to enhance recovery are limited. Emerging evidence highlights the gut microbiota as a crucial regulator of post-stroke inflammation, neuroplasticity, and systemic health. Post-stroke gut dysbiosis disrupts intestinal barrier integrity, alters microbial metabolite profiles, and drives maladaptive immune responses, negatively influencing neurological recovery. Preclinical studies indicate that probiotics, fecal microbiota transplantation (FMT), and short-chain fatty acid (SCFA) supplementation can reduce neuroinflammation and improve functional outcomes. This narrative review synthesizes mechanistic insights and clinical findings, emphasizing studies by Benakis et al. (2016), Singh et al. (2016), Peh et al. (2022), Zhao et al. (2018), Lee et al. (2020), and Hammond et al. (2022). We also discuss microbiota-targeted therapeutic strategies, current challenges, and future directions for translating these findings into personalized interventions.

Keywords- Stroke, Gut microbiota, dysbiosis.

Editorial Policy

Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not ..

Read More.....

Frequency of Publication

JMSCR is published as monthly journal with 12 issues per year. Special editions are also planned subjected to the scope and need....

Read more...

Submission of Articles

Authors are invited to submit their research articles, review papers, Case Report properly formatted as per the author guidelines.........

Read more...